Nexus Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,000
| Closed | -$462K | – | 75 |
|
|
2024
Q2 | $462K | Sell |
6,000
-406,399
| -99% | -$31.3M | 0.05% | 61 |
|
|
2024
Q1 | $28.2M | Buy |
412,399
+2,500
| +0.6% | +$171K | 2.72% | 19 |
|
|
2023
Q4 | $23.7M | Buy |
409,899
+625
| +0.2% | +$36.1K | 2.47% | 23 |
|
|
2023
Q3 | $21.6M | Sell |
409,274
-2,075
| -0.5% | -$110K | 2.44% | 22 |
|
|
2023
Q2 | $22.2M | Buy |
411,349
+3,115
| +0.8% | +$168K | 2.42% | 26 |
|
|
2023
Q1 | $20.4M | Sell |
408,234
-2,500
| -0.6% | -$125K | 2.25% | 27 |
|
|
2022
Q4 | $19M | Buy |
410,734
+500
| +0.1% | +$23.1K | 2.15% | 27 |
|
|
2022
Q3 | $15.9M | Buy |
410,234
+6,100
| +2% | +$236K | 1.98% | 26 |
|
|
2022
Q2 | $15.1M | Buy |
404,134
+3,600
| +0.9% | +$134K | 1.73% | 29 |
|
|
2022
Q1 | $17.7M | Buy |
400,534
+5,900
| +1% | +$261K | 1.86% | 26 |
|
|
2021
Q4 | $16.8M | Sell |
394,634
-9,300
| -2% | -$395K | 1.71% | 28 |
|
|
2021
Q3 | $17.5M | Sell |
403,934
-141
| -0% | -$6.12K | 1.89% | 27 |
|
|
2021
Q2 | $17.3M | Buy |
404,075
+2,600
| +0.6% | +$111K | 1.79% | 27 |
|
|
2021
Q1 | $15.5M | Buy |
401,475
+150
| +0% | +$5.8K | 1.77% | 26 |
|
|
2020
Q4 | $13.9M | Buy |
401,325
+49,175
| +14% | +$1.7M | 1.79% | 25 |
|
|
2020
Q3 | $13.5M | Buy |
+352,150
| New | +$13.5M | 2.04% | 23 |
|